4.4 Article

Markov Influence Diagrams: A Graphical Tool for Cost-effectiveness Analysis

Journal

MEDICAL DECISION MAKING
Volume 37, Issue 2, Pages 183-195

Publisher

SAGE PUBLICATIONS INC
DOI: 10.1177/0272989X16685088

Keywords

Markov models; influence diagrams; cost-effectiveness analysis; outcomes research

Funding

  1. Spanish Ministry of Education and Science [TIN2006-11152]
  2. Ministry of Science and Technology [TIN2009-09158]
  3. FONCICYT [95185]
  4. 7th Frame Programme [262266, FP7-PEOPLE-2012-IAPP-324401]
  5. Health Institute Carlos III of the Spanish Government [PI13/02446]
  6. European Regional Development Fund
  7. UNED
  8. MED-EL GmbH
  9. Ministry of Education, Science and Sport
  10. Santander Bank-UNED mobility grant
  11. Ministry of Science and Technology

Ask authors/readers for more resources

Markov influence diagrams (MIDs) are a new type of probabilistic graphical model that extends influence diagrams in the same way that Markov decision trees extend decision trees. They have been designed to build state-transition models, mainly in medicine, and perform cost-effectiveness analyses. Using a causal graph that may contain several variables per cycle, MIDs can model various patient characteristics without multiplying the number of states; in particular, they can represent the history of the patient without using tunnel states. OpenMarkov, an open-source tool, allows the decision analyst to build and evaluate MIDsincluding cost-effectiveness analysis and several types of deterministic and probabilistic sensitivity analysiswith a graphical user interface, without writing any code. This way, MIDs can be used to easily build and evaluate complex models whose implementation as spreadsheets or decision trees would be cumbersome or unfeasible in practice. Furthermore, many problems that previously required discrete event simulation can be solved with MIDs; i.e., within the paradigm of state-transition models, in which many health economists feel more comfortable.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available